Genoclone Pharmaceuticals Private Limited
About Genoclone Pharmaceuticals Private Limited
Data last updated:
Genoclone Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 13 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2020PTC126993. Its GSTIN is 09AAICG2267L1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹20,000. It is led by directors Bhagwati Sharma and Vaibhav Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 906 Tower No – 18 River Heights Complex Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.48 Lakh. For the same year it recorded a net loss of ₹2.53 Lakh (net margin -39.1%) and EBITDA of -₹2.53 Lakh (EBITDA margin -39.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
Company details
Contact details
Genoclone Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressF – 906 Tower No – 18 River Heights Complex Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Genoclone Pharmaceuticals Private Limited
FY 2025 filings availableGenoclone Pharmaceuticals Private Limited reported revenue of ₹6.48 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years. EBITDA fell 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -39.1% | ||||
| Net Profit Margin | -39.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genoclone Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genoclone Pharmaceuticals Private Limited
Genoclone Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagwati Sharma | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
| Vaibhav Vyas | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Genoclone Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seignior Pharmaceuticals Private Limited | ₹6.51 Lakh (FY 2024) | -36.0% | Cuttack, Odisha, India | |||
| Avira Pharmaceuticals Private Limited | ₹6.51 Lakh (FY 2025) | Gurgaon, Haryana, India | ||||
| Trams Pharmaceuticals Private Limited | ₹6.5 Lakh (FY 2024) | -11.0% | Pune, Maharashtra, India | |||
| Pradocia Pharmaceuticals Private Limited | ₹6.49 Lakh (FY 2020) | 252.0% | Pune, Maharashtra, India | |||
| Inpra Pharmaceuticals Private Limited | ₹6.49 Lakh (FY 2020) | 147.0% | Mumbai, Maharashtra, India | |||
| Genoclone Pharmaceuticals Private Limitedthis company | ₹6.48 Lakh (FY 2025) | -₹2.53 Lakh | -39.1% | Ghaziabad, Uttar Pradesh, India | ||
| Define Pharmaceuticals Private Limited | ₹6.46 Lakh (FY 2025) | 3.0% | Ranpur, Odisha, India | |||
| Pinewave Pharmaceuticals Private Limited | ₹6.41 Lakh (FY 2025) | 593.0% | Delhi, India | |||
| Moba Pharmaceuticals Private Limited | ₹6.41 Lakh (FY 2025) | -16.0% | Delhi, India | |||
| Certes Pharmaceuticals Company Private Limited | ₹6.4 Lakh (FY 2023) | -56.0% | Kolkata, West Bengal, India | |||
| Macmed Pharmaceuticals Private Limited | ₹6.39 Lakh (FY 2025) | 44.0% | Varanasi, Uttar Pradesh, India |
To see the full peer comparison of Genoclone Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genoclone Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genoclone Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genoclone Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICG2267L1Z6 | Uttar Pradesh | Active | 23 Mar 2020 |
To see the full GST registrations and return filing status of Genoclone Pharmaceuticals Private Limited, buy the company report.
Recent activity
Genoclone Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bhagwati Sharma was appointed as Director on 13 Feb 2020.
Frequently asked questions
Genoclone Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 13 February 2020 (6+ years old) and is registered under CIN U51909UP2020PTC126993.
Genoclone Pharmaceuticals has 2 current directors:
- Bhagwati Sharma - Director
- Vaibhav Vyas - Director
The latest financial statements of Genoclone Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Genoclone Pharmaceuticals is 09AAICG2267L1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Genoclone Pharmaceuticals is U51909UP2020PTC126993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genoclone Pharmaceuticals was incorporated on 13 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Genoclone Pharmaceuticals by revenue are Seignior Pharmaceuticals Private Limited, Avira Pharmaceuticals Private Limited, Trams Pharmaceuticals Private Limited, Pradocia Pharmaceuticals Private Limited, Inpra Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Bhagwati Sharma was appointed as Director on 13 Feb 2020. Vaibhav Vyas was appointed as Director on 13 Feb 2020.
The registered office of Genoclone Pharmaceuticals is at F – 906 Tower No – 18 River Heights Complex Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017.
Genoclone Pharmaceuticals operates in the trading industry, in the specialty segment.
Genoclone Pharmaceuticals can be reached at its registered office: F – 906 Tower No – 18 River Heights Complex Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
